Biowin Pharma (India) Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L

More

• Share holding
• Capital structures

Mar ' 99

Sources of funds

Owner's fund

Equity share capital

5.05

Share application money

-

Preference share capital

-

Reserves & surplus

1.58

Loan funds

Secured loans

4.86

Unsecured loans

-

Total

11.49

Uses of funds

Fixed assets

Gross block

3.20

Less : revaluation reserve

-

Less : accumulated depreciation

0.15

Net block

3.05

Capital work-in-progress

0.17

Investments

0.01

Net current assets

Current assets, loans & advances

10.38

Less : current liabilities & provisions

2.42

Total net current assets

7.96

Miscellaneous expenses not written

0.31

Total

11.49

Notes:

Book value of unquoted investments

0.01

Market value of quoted investments

-

Contingent liabilities

0.14

Number of equity sharesoutstanding (Lacs)

50.51